| Adnan Misellati, MD | |
|
7117 Brockton Ave, Riverside, CA 92506-2658 | |
| (951) 782-3616 | |
| Not Available |
| Full Name | Adnan Misellati |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 7117 Brockton Ave, Riverside, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063654564 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 115540 (California) | Secondary |
| 207Q00000X | Family Medicine | A115540 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Belmont Hospice Inc | Upland, CA | Hospice |
| Riverside Community Hospital | Riverside, CA | Hospital |
| Victor Valley Global Medical Center | Victorville, CA | Hospital |
| Parkview Community Hospital Medical Center | Riverside, CA | Hospital |
| San Antonio Regional Hospital | Upland, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverside Medical Clinic Inc | 2961492327 | 149 |
| Galen Inpatient Physicians Pc | 3678464633 | 345 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.
As success rates in treating childhood cancers have improved, greater emphasis is being placed on quality of life issues following successful treatment.
Sparton Corporation announced that it has joined the Russell Microcap® Index according to the list posted June 28, 2010 on www.russell.com.
Researchers say that taking early and repeat white blood cell counts could help determine which children with pertussis are at highest risk for death.
› Verified 4 days ago
| Entity Name | Galen Inpatient Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689320459 PECOS PAC ID: 3678464633 Enrollment ID: O20040322000680 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.
As success rates in treating childhood cancers have improved, greater emphasis is being placed on quality of life issues following successful treatment.
Sparton Corporation announced that it has joined the Russell Microcap® Index according to the list posted June 28, 2010 on www.russell.com.
Researchers say that taking early and repeat white blood cell counts could help determine which children with pertussis are at highest risk for death.
› Verified 4 days ago
| Entity Name | Riverside Medical Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720183403 PECOS PAC ID: 2961492327 Enrollment ID: O20040517000880 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.
As success rates in treating childhood cancers have improved, greater emphasis is being placed on quality of life issues following successful treatment.
Sparton Corporation announced that it has joined the Russell Microcap® Index according to the list posted June 28, 2010 on www.russell.com.
Researchers say that taking early and repeat white blood cell counts could help determine which children with pertussis are at highest risk for death.
› Verified 4 days ago
| Entity Name | Quantum Healthcare Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568490597 PECOS PAC ID: 5294647574 Enrollment ID: O20040924000422 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.
As success rates in treating childhood cancers have improved, greater emphasis is being placed on quality of life issues following successful treatment.
Sparton Corporation announced that it has joined the Russell Microcap® Index according to the list posted June 28, 2010 on www.russell.com.
Researchers say that taking early and repeat white blood cell counts could help determine which children with pertussis are at highest risk for death.
› Verified 4 days ago
| Entity Name | Inpatient Specialists Of California Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952792475 PECOS PAC ID: 3476864448 Enrollment ID: O20150617000915 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.
As success rates in treating childhood cancers have improved, greater emphasis is being placed on quality of life issues following successful treatment.
Sparton Corporation announced that it has joined the Russell Microcap® Index according to the list posted June 28, 2010 on www.russell.com.
Researchers say that taking early and repeat white blood cell counts could help determine which children with pertussis are at highest risk for death.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adnan Misellati, MD 7117 Brockton Ave, Riverside, CA 92506-2658 Ph: (951) 782-3616 | Adnan Misellati, MD 7117 Brockton Ave, Riverside, CA 92506-2658 Ph: (951) 782-3616 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.
As success rates in treating childhood cancers have improved, greater emphasis is being placed on quality of life issues following successful treatment.
Sparton Corporation announced that it has joined the Russell Microcap® Index according to the list posted June 28, 2010 on www.russell.com.
Researchers say that taking early and repeat white blood cell counts could help determine which children with pertussis are at highest risk for death.
› Verified 4 days ago
Miriam Cho, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7117 Brockton Ave, Riverside, CA 92506 Phone: 951-321-6504 Fax: 951-784-3271 | |
Sung Jin John, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 909-353-2000 | |
Dr. Denise A Martinez, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3390 University Ave Ste 100, Riverside, CA 92501 Phone: 844-827-8000 | |
Nathan Hao Hsin Yen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6405 Day St, Riverside, CA 92507 Phone: 951-697-5427 Fax: 951-697-5516 | |
Dr. Janis Neuman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7140 Indiana Ave, Riverside, CA 92504 Phone: 951-358-6000 Fax: 951-358-6044 | |
Wayne Dysinger, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4368 Central Ave, Riverside, CA 92506 Phone: 951-742-7324 Fax: 951-394-7267 | |
Karl Tanara, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7117 Brockton Ave, Riverside, CA 92506 Phone: 951-782-3715 Fax: 951-784-3275 |